We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Sanofi and Regeneron have modified their clinical trial of the rheumatoid arthritis drug Kevzara (sarilumab) as a COVID-19 treatment after preliminary results found no benefit in one group. Read More
In a letter to the FDA last week, 35 federal lawmakers recommend the agency consider approving human “challenge” trials for COVID-19, which would infect healthy volunteers with the deadly virus to test efficacy of a vaccine. But the FDA and some researchers have expressed concern over the ethics involved. Read More
AstraZeneca has begun a phase 3 clinical trial to evaluate its diabetes drug Farxiga (dapagliflozin) as a possible treatment for hospitalized COVID-19 patients. Read More
Results from a Chinese trial of Gilead’s antiviral remdesivir show no benefit in COVID-19 patients, according to data accidentally posted on the World Health Organization’s (WHO) website. Read More
With dozens of clinical trials of hydroxychloroquine as a COVID-19 treatment currently in the planning or enrollment stages, there are mounting concerns that the drug’s risks could outweigh the benefits for COVID-19 patients. Read More